Artwork

Contenuto fornito da Michael Frazis. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Michael Frazis o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Player FM - App Podcast
Vai offline con l'app Player FM !

Episode 48: SALT interview with Rachel Pether - true love and explosive growth

39:38
 
Condividi
 

Manage episode 316836604 series 3126091
Contenuto fornito da Michael Frazis. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Michael Frazis o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.

Michael Frazis describes his investment company’s strategy that involves a 30-40 year view, not panicking and diverting the approach during dips and rallies. Evaluating growth stocks involves identifying customer love for a product or service which acts a key indicator of explosive growth potential. This approach is utilized in picking winners in industries like the ‘buy now, pay later’ space. Frazis explains how vaccine development is a long process involving extensive trials and how the emergency approval of Moderna’s vaccine allowed the company to prove the mRNA concept, providing the company a significant boost.

TIMESTAMPS

0:00 - Intro and background

2:39 - Founding his company at 29 and investing strategy

11:38 - Evaluating polarizing stocks like Tesla

15:08 - Investing psychology

18:45 - Processing investment information

23:17 - Investing in industry creators

25:31 - Moderna and life sciences investments

31:43 - Dogecoin case study

35:30 - Growth stocks amid inflation

  continue reading

89 episodi

Artwork
iconCondividi
 
Manage episode 316836604 series 3126091
Contenuto fornito da Michael Frazis. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Michael Frazis o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.

Michael Frazis describes his investment company’s strategy that involves a 30-40 year view, not panicking and diverting the approach during dips and rallies. Evaluating growth stocks involves identifying customer love for a product or service which acts a key indicator of explosive growth potential. This approach is utilized in picking winners in industries like the ‘buy now, pay later’ space. Frazis explains how vaccine development is a long process involving extensive trials and how the emergency approval of Moderna’s vaccine allowed the company to prove the mRNA concept, providing the company a significant boost.

TIMESTAMPS

0:00 - Intro and background

2:39 - Founding his company at 29 and investing strategy

11:38 - Evaluating polarizing stocks like Tesla

15:08 - Investing psychology

18:45 - Processing investment information

23:17 - Investing in industry creators

25:31 - Moderna and life sciences investments

31:43 - Dogecoin case study

35:30 - Growth stocks amid inflation

  continue reading

89 episodi

Tutti gli episodi

×
 
Loading …

Benvenuto su Player FM!

Player FM ricerca sul web podcast di alta qualità che tu possa goderti adesso. È la migliore app di podcast e funziona su Android, iPhone e web. Registrati per sincronizzare le iscrizioni su tutti i tuoi dispositivi.

 

Guida rapida